The effect of casein phosphopeptide amorphous calcium phosphate fluoride paste (CPP-ACPF) on oral and salivary conditions of patients undergoing chemotherapy
A randomized controlled clinical trial
Keywords:
Oral complication, dental plaque, saliva, casein phosphopeptide amorphous calcium phosphateAbstract
Background: Oral and saliva conditions of patients undergoing chemotherapy is often affected by the medication they receive. Up to now, no appropriate medication that possesses the positive effects of chemotherapy without presenting oral complications has been introduced.
Objective: The aim of this study was to assess the clinical effects of CPP-ACPF paste on the oral and salivary status of patients undergoing chemotherapy.
Methods: From October 2013 to April 2014, 20 patients in chemotherapy treatment plans and who met the inclusion criteria enrolled in this randomized parallel single-blind controlled clinical trial in Shohada-e-Tajrish Hospital in Tehran, Iran. Patients were divided into two groups: 1) patients received their daily medication of cancer therapy center (group 1, control); 2) patients applied CPP-ACPF Crème (MI paste plus, GC USA) twice a day as instructed (group 2). The baseline status of oral conditions of patients (mucositis, dry mouth, infection, diminished tasting sense, difficulty in food intake, burning sensation of mucosa, saliva and dental plaque pH, rest and stimulated saliva, buffering capacity of saliva) were recorded and reevaluated after 21 and 42 days. The data were analyzed with a Mann-Whitney U-test.
Results: A total of 20 patients were allocated randomly to groups 1 and 2. The Mann-Whitney U-test showed that application of CPP-ACPF paste twice daily did not cause any significant difference in oral complication of the subject group compared with the control group (p>0.05). Among salivary signs, resting and stimulated saliva rates and saliva buffering capacity had significantly altered in the CPP-ACPF group in day 21 and 42 in comparison with those of the control group (p<0.05).
Conclusion: Application of CPP-ACPF paste before and during chemotherapy can improve the salivary status of patients undergoing this treatment.
Trial registration: The trial is registered at the U.S. National Institutes of Health (https://www.clinicaltrials.gov) with the identification number NCT01737307.
Funding: The authors received no financial support for the research, authorship, and/or publication of this article.
References
Corti L, Chiarion-Sileni V, Aversa S, Ponzoni A, D’Arcais R, PagnuttiS. Treatment of chemotherapyinduced oral mucositis with light-emitting diode. Photomed Laser Surg. 2006; 24: 207-13. doi:
1089/pho.2006.24.207, PMID: 16706701.
Lowe O. Pretreatment dental assessment and management of patients undergoing head and neck irradiation.
ClinPrev Dent.1988; 8: 24-30.
Blom M, Dawidson I, Fernberg JO, Johnson G, Angmar-Månsson B. Acupuncture treatment of patients
with radiation-induced xerostomia. Eur J Cancer B Oral Oncol.1996; 32(3):182–90. PMID: 8762876
Toth BB, Martin JW, Fleming TJ. Oral complications associated withcancer therapy. J ClinPeriodontol.
; 17: 508–15. doi: 10.1111/j.1365-2710.1992.tb01225.x, PMID: 220274.
Xelson P, O¨ slund L, Hontwedt M, Paulaner J.The effect of threedifferent mouthrinses on plaqueformation
rate and salivary levels of mutans streptococci and lactobacilli. Eur J Dent. 2009; 3(1): 57–61.
Rosenthal DI, Lewin JS, Eisbruch A. Prevention and treatment of dysphagia and aspiration after
chemoradiation for head and neck cancer. JClinOncol. 2006; 24: 2636-43. doi: 10.1200/JCO.2006.06.0079,
PMID: 16763277.
Hay K,Thomson W. Clinical trial of the anticaries efficacy of casein derivatives complexed with calcium
phosphate in patients with salivary gland dysfunction. OralSurg Oral Med Oral Pathol Oral RadiolEndod
; 93(3) 271-5. doi: 10.1067/moe.2002.120521, PMID: 11925535.
Ramalingam L, Messer LB, Reynolds EC. Adding casein phosphopeptide-amorphous calcium phosphate to
sports drinks to eliminate in vitro erosion. Pediatr Dent. 2005 Jan-Feb;27(1):61-7. PMID: 15839397
Heshmat H, Banava S, Mohammadi E, Kharazifard MJ, Mojtahedzadeh F. The effect of recommending a
CPP-ACPF product on salivary and plaque pH levels in orthodontic patients: a randomized cross-over
clinical trial. Acta Odontol Scand. 2014 Nov;72(8):903-7. doi: 10.3109/00016357.2014.920515, PMID:
Hegde MN, Moany A. Remineralization of enamel subsurface lesions with casein phosphopeptide- amorphous calcium phosphate: A quantitative energy dispersive X-ray analysis using scanning electron
microscopy: An in vitro study. J Conserv Dent. 2012; 15: 61-7. doi: 10.4103/0972-0707.92609, PMID:
, PMCID: PMC3284017.
World Health Organization. WHO handbook for reporting results in cancer treatment. Geneva,
Switzerland: World Health Organization, 1979: WHO Offset Publication No. 48. Available from:
http://whqlibdoc.who.int/offset/WHO_OFFSET_48.pdf
Vendrell Ranki. Oral health in cancer therapy. 3rd ed. 2008.
Mosalaei A, Nasrolahi H, Shafizad H, Ahmadloo N, Ansari M, Mosleh-Shirazi M, et al. Effect of Oral Zinc
Sulphate in Prevention of Radiation Induced Oropharyngeal Mucositis During and After Radiotherapy in
Patients with Head and Neck Cancers. MEJC. 2010; 1(2): 69-76
Tiemann P, Toelg M, Ramos F MH. Administration of Ratanhia-based herbal oral care products for the
prophylaxis of oral mucositis in cancer chemotherapy patients: a clinical trial. Evid Based Complement
Alternat Med. 2007 Sep;4(3):361-6. PMID: 17965768, PMCID: PMC1978231
Roberts MJ, Messer LB, Reynolds EC. Remineralisation of fluorotic enamel lesions by casein
phosphopeptide –amorphous calcium fluorophosphate (CPP-ACFP) solution. IADR-ANZ Division,
Abstract 54,2000
Carl W. Xerostomia Management in the Head and Neck Radiation Patient, Texas dental journal. 2004;
(6): 483-97.
Mayne RJ, Cochrane N, Cai F, Woods M, Reynolds E. In-vitro study of the effect of casein phosphopeptide
amorphous calcium fluoride phosphate on iatrogenic damage to enamel during orthodontic adhesive
removal. Am J Orthod Dentofacial Orthop. 2011; 139(6): 543-51. doi: 10.1016/j.ajodo.2010.09.027, PMID:
Douglas E. Peterson, James B. Jones, Robert G. Randomized, Placebo-Controlled Trial of Saforis for
Prevention and Treatment of Oral Mucositis in Breast Cancer Patients Receiving Anthracycline-Based
chemotherapy. Cancer. 2007; 109(2): 322–331
Singh ML, Papas AS. Long-term clinical observation of dental caries in salivary hypofunction patients
using a supersaturated calcium-phosphate remineralizing rinse. J Clin Dent. 2009;20 (3):87-92. PMID:
Published
Issue
Section
License
Copyright (c) 2020 knowledge kingdom publishing
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
